Photo: Nicholas Kamm/AFP/Getty Images

The White House, in conjunction with the Ad Council, next week will debut public service messages on opioid dangers that were described to us as having a "shock the conscience" rawness.

What to expect: We hear President Trump, who doesn't appear in the ads, likes the starkness of the classic "Your Brain on Drugs" messages, and wanted a similar toughness. "He thinks you have to engage and enrage," a source said.

  • The messages, which were focus-grouped and are aimed at youths, include links to learn more, or get help for someone you know.
  • White House counselor Kellyanne Conway is Trump's point person on opioids, and she has been working with the Cabinet and Congress.
  • Opioids are a rare policy issue involving both the president and First Lady Melania Trump.

The backdrop: After a speech by Trump on opioids in March, the N.Y. Times said he "offered up more tough talk than he did specifics about his plan, or how he would pay for it."

  • When Trump's budget was released in February, Keith Humphreys, a Stanford drug policy expert who served in the Obama administration, told Vox: "On balance, this is a net cut in health services for people with opioid problems."

Go deeper

Former officer who shot Breonna Taylor indicted on wanton endangerment

A memorial to Breonna Taylor in downtown Louisville, Kentucky on Sept. 23. Photo: Jeff Dean/AFP via Getty Images

A grand jury has indicted Brett Hankison, one of the Louisville police officers who entered Breonna Taylor's home in March and shot her at least eight times, on three counts of wanton endangerment.

The state of play: None of the three officers involved in the botched drug raid will face charges related to the actual death of Taylor, such as homicide or manslaughter. The two other officers, Jonathan Mattingly and Myles Cosgrove, were not charged at all. Hankison's bond was set at $15,000.

FDA chief vows agency will not accept political pressure on coronavirus vaccine

Food and Drug Administration Commissioner Stephen Hahn promised that "science will guide our decision" for a coronavirus vaccine at a Senate hearing on Wednesday.

Why it matters: More Americans are expressing doubt about a first-generation vaccine, despite President Trump's efforts to push an unrealistic timeline that conflicts with medical experts in his administration.

CEO confidence rises for the first time in over 2 years

Data: Business Roundtable; Chart: Naema Ahmed/Axios

A closely-watched CEO economic confidence index rose for the first time after declining for nine straight quarters, according to a survey of 150 chief executives of the biggest U.S. companies by trade group Business Roundtable.

Why it matters: The index, which still remains at a decade low, reflects corporate America's expectations for sales, hiring and spending — which plummeted amid uncertainty when the pandemic hit.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!